Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × veliparib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Biopsy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 ruxolitinib 3 X-Rays 3 Vincristine 3 10-propargyl-10-deazaaminopterin 3 venetoclax 2 tazemetostat 2 sodium-iodide symporter 2 pembrolizumab 2 duvelisib 2 cemiplimab 2 belinostat 2 Prednisone 2 Photons 2 Nivolumab 2 Ipilimumab 2 Immunoglobulin G 2 Etoposide 2 Doxorubicin 2 Disulfides 2 CTLA-4 Antigen 2 Azacitidine 2 zanubrutinib 1 talimogene laherparepvec 1 nelarabine 1 mogamulizumab 1 enasidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡